Brain Tumor Reports
54

Volume 19 Number 1
January 2017


Home > Publications > Brain Tumor Reports > Volume 19, Year 2017 > Number 1, January


CONTENTS



BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS
MEDULLOBLASTOMA
PILOCYTIC ASTROCYTOMA





BRAIN TUMORS



Becher OJ, Gilheeney SW, Khakoo Y, Lyden DC, Haque S, De Braganca KC, Kolesar JM, Huse JT, Modak S, Wexler LH, Kramer K, Spasojevic I, Dunkel IJ.
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.
Pediatr Blood Cancer. 2016 Dec 30. doi: 10.1002/pbc.26409. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, Ostberg JR, Blanchard MS, Kilpatrick J, Simpson J, Kurien A, Priceman SJ, Wang X, Harshbarger TL, D'Apuzzo M, Ressler JA, Jensen MC, Barish ME, Chen M, Portnow J, Forman SJ, Badie B.
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
N Engl J Med. 2016 Dec 29;375(26):2561-9. doi: 10.1056/NEJMoa1610497.
Source | Abstract | Full text | Similar articles




Cloughesy T, Finocchiaro G, Belda-Iniesta C, Recht L, Brandes AA, Pineda E, Mikkelsen T, Chinot OL, Balana C, Macdonald DR, Westphal M, Hopkins K, Weller M, Bais C, Sandmann T, Bruey JM, Koeppen H, Liu B, Verret W, Phan SC, Shames DS.
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA Methyltransferase Biomarker Analyses.
J Clin Oncol. 2017 Jan 20;35(3):343-351. doi: 10.1200/JCO.2015.64.7685. Epub 2016 Dec 5.
Source | Abstract | Full text | Similar articles




Klement RJ, Champ CE.
Corticosteroids compromise survival in glioblastoma in part through their elevation of blood glucose levels.
Brain. 2016 Dec 21. pii: aww324. doi: 10.1093/brain/aww324. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




O'Connell D, Shen V, Loudon W, Bota DA.
First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: a case report.
CNS Oncol. 2017 Jan;6(1):11-18. doi: 10.2217/cns-2016-0018. Epub 2016 Dec 5.
Source | Abstract | Full text | Similar articles




Peddi P, Ajit NE, Burton GV, El-Osta H.
Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam.
BMJ Case Rep. 2016 Dec 23;2016. pii: bcr2016217393. doi: 10.1136/bcr-2016-217393.
Source | Abstract | Full text | Similar articles




Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker CA, Jones TS, Hentschel B, Gorlia T, Schlegel U, Stupp R, Weller M, Holland EC, Hambardzumyan D.
Corticosteroids compromise survival in glioblastoma.
Brain. 2016 May;139(Pt 5):1458-71. doi: 10.1093/brain/aww046. Epub 2016 Mar 28.
Source | Abstract | Full text | Similar articles




Smith AW, Parashar B, Wernicke AG.
Subventricular zone-associated glioblastoma: A call for translational research to guide clinical decision making.
Neurogenesis (Austin). 2016 Aug 19;3(1):e1225548.
Source | Abstract | Full text | Similar articles




Sulman EP, Ismaila N, Chang SM.
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
J Oncol Pract. 2016 Nov 29:JOP2016018937. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Weller M, Holland EC, Hambardzumyan D.
Reply: Corticosteroids compromise survival in glioblastoma in part through their elevation of blood glucose levels.
Brain. 2016 Dec 21. pii: aww325. doi: 10.1093/brain/aww325. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Yoo RE, Choi SH, Kim TM, Park CK, Park SH, Won JK, Kim IH, Lee ST, Choi HJ, You SH, Kang KM, Yun TJ, Kim JH, Sohn CH.
Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.
Eur Radiol. 2016 Dec 14. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zwirner K, Paulsen F, Schittenhelm J, Borchers C, Skardelly M, Zips D, Eckert F.
Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.
Acta Neurol Scand. 2016 Dec 26. doi: 10.1111/ane.12719. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOMAS



HIGH-GRADE GLIOMAS


de Lemos ML, Markarian A, Chan E, Schaff K, Walisser S.
Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation.
J Oncol Pharm Pract. 2016 Nov 30. pii: 1078155216681191. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Portnow J, Synold TW, Badie B, Tirughana R, Lacey SF, D'Apuzzo M, Metz MZ, Najbauer J, Bedell V, Vo T, Gutova M, Frankel P, Chen MY, Aboody KS.
Neural stem cell-based anti-cancer gene therapy: a first-in-human study in recurrent high grade glioma patients.
Clin Cancer Res. 2016 Dec 15. pii: clincanres.1518.2016. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




LOW-GRADE GLIOMAS


Darlix A, Gozé C, Rigau V, Bauchet L, Taillandier L, Duffau H.
The etiopathogenesis of diffuse low-grade gliomas.
Crit Rev Oncol Hematol. 2017 Jan;109:51-62. doi: 10.1016/j.critrevonc.2016.11.014. Epub 2016 Nov 27.
Source | Abstract | Full text | Similar articles





MEDULLOBLASTOMA



Esbenshade AJ, Kocak M, Hershon L, Rousseau P, Decarie JC, Shaw S, Burger P, Friedman HS, Gajjar A, Moghrabi A.
A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group.
Pediatr Blood Cancer. 2016 Dec 21. doi: 10.1002/pbc.26373. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





PILOCYTIC ASTROCYTOMA



Miller C, Guillaume D, Dusenbery K, Clark HB, Moertel C.
Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: documentation of volumetric response.
J Neurosurg Pediatr. 2016 Dec 23:1-6. doi: 10.3171/2016.9.PEDS16328. [Epub ahead of print]
Source | Abstract | Full text | Similar articles